Viewing Study NCT06552858


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2026-04-11 @ 10:22 AM
Study NCT ID: NCT06552858
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-14
First Post: 2024-08-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ovarian cancer View
None platinum resistance View
None Fluzoparib View
None Dalpiciclib View